NR2F1 Foundation Issues Bioinformatics Analysis Grant to Dr Laugsch

 

The Word Biomarkers is in a circle with arrows pointing out to the following words: research examination proof disease biology diagnostic prevention health condition treatment body indicator process response

Biomarkers are the key to discovering effective and meaningful treatment

The NR2F1 Foundation issued a grant to Dr Magdalena Laugsch at Heidelberg University to fund bioinformatics analysis and workflow establishment for biomarker discovery in NR2F1 and BBSOAS (Bosch-Boonstra-Schaaf optic atrophy syndrome) using plasma proteomics samples data.

The NR2F1 Foundation has worked tirelessly over the course of the last 2 years to collect biorepository samples (blood and urine) from BBSOAS patients, and their families.  Thanks to a partnership with COMBINEDBrain those samples have been turned into data and are now being analyzed to identify potential biomarkers.
A biomarker is a biological molecule or characteristic that indicates a normal or abnormal process, condition, or disease in the body. *Biological markers (biomarkers) are characteristics that can be objectively measured and used as an indicator of normal biological processes, disease processes, or pharmacologic responses to a therapy. Biomarkers are important for the development of drugs, biologics, and certain medical devices.
 
Over the course of 6 months Dr Laugsch and her team hope to learn more about BBSOAS and we look forward to sharing what we learn.
 
A big thanks to Dr Laugsch and her team at the Schaaf lab at Heidelberg University for their ongoing partnership and dedication to our mission to support families worldwide wide living with rare NR2F1 gene variants through education, advocacy and research.
*NIH.gov
Carlie Monnier
Vice President of Board of Directors at  | Website

Carlie is the Vice President of the Board of Directors for the NR2F1 Foundation, a registered 501(c)(3) non-profit organization dedicated to those living with rare mutations on the Nr2f1 gene.

With a B.S. in Special Education and a M.S. in Counseling, Carlie has worked at EPU Children’s Center as a Resource Specialist serving parents of children living with disabilities and then directed a parent leadership group for disability advocacy through storytelling and public speaking.

Carlie lives with her husband Jeff and their two daughters, one of whom has the rare Nr2f1 gene mutation, in Royal Oak, Michigan. She wants all Nr2f1 families whose lives have changed dramatically to know they are not alone.

Related Blogs

NR2F1 Foundation President Jen stands in front of a large banner for NORD that says reimagining what is possible
Dr. Magdalena Laugsch with her students, Ayat and Michael